Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
robertinio 
19.02.24 0%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.01
18.02.24
-
18.02.25
-2.59%
03.03.24

Risky Investment
blaugold 
18.02.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.70
17.02.24
€14.00
17.02.25
2.15%
23.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
17.02.24 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.50
15.02.24
-
15.02.25
-3.09%
17.02.24

Risky Investment
daimler1 
15.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.02
13.02.24
-
13.02.25
5.94%
17.02.24

Probably not worthwhile Investment
Vassago1 
13.02.24 50%
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€110.70
10.02.24
-
10.02.25
0.54%
15.02.24

Dirk1 
10.02.24 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
29.34%
06.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
me8 
05.02.24 0%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
05.02.24 0%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.72
05.02.24
-
05.02.25
24.42%
17.02.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
05.02.24 0%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
me8 
05.02.24 0%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.05
03.02.24
-
03.02.25
1.90%
17.02.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
03.02.24 0%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€40.95
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

MBU 
31.01.24 50%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.65
30.01.24
-
30.01.25
-1.41%
31.01.24

Saftman 
30.01.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
quelbe60 
29.01.24 50%
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€0.99
29.01.24
€1.00
29.01.25
-49.90%
03.02.24

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
me8 
29.01.24 0%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
25.01.24
€110.00
31.03.26
-0.66%
02.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 80%
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 70%
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.21
23.01.24
-
23.01.25
-15.48%
03.02.24

Probably not worthwhile Investment
Vassago1 
23.01.24 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.38
22.01.24
-
22.01.25
14.50%
03.02.24

Could be very worthwhile Investment >20% year
michaelkr 
22.01.24 50%
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.92
22.01.24
-
22.01.25
-36.03%
03.02.24

Probably not worthwhile Investment
michaelkr 
22.01.24 50%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.54
21.01.24
-
21.01.25
6.61%
03.02.24

Could be worthwhile Investment >10% per year
Vassago1 
21.01.24 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.67
21.01.24
-
21.01.25
18.80%
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
21.01.24 50%